Skip to content

A prospective observational study of comparison between radical prostatectomy and radiation therapy for high risk prostate cancer

A prospective observational study of comparison between radical prostatectomy and radiation therapy for high risk prostate cancer - A prospective observational study of comparison between radical prostatectomy and radiation therapy for high risk prostate cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033343
Enrollment
90
Registered
2018-07-10
Start date
2018-05-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Sponsors

Saitama Medical University International Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients suspected of having prostate cancer due to PSA at the first visit. Patients diagnosed with high-risk prostate cancer who have no distant metastases. Patients over the age of 20 at the time of obtaining consent. Patients who can obtain written informed consent.

Exclusion criteria

Exclusion criteria: Patients who were not tested for high-risk prostate cancer or were found to have metastatic prostate cancer as a result of further testing (however, data and samples up to that point are used for preliminary analysis).

Design outcomes

Primary

MeasureTime frame
Blood / urinalysis, physical findings, tumor assessment of prostate and pelvic lymph nodes (non-contrast MRI) are performed every 3 months.

Secondary

MeasureTime frame
Evaluation of complications (international prostate symptom score IPSS (6)), quality of life after surgery (EuroQol 5 Dimension; EQ - 5D (7) and FACT - P (8)) and erectile function (International erectile function score; Evaluation of IIEF 5 (9)) every 3 months.

Countries

Japan

Contacts

Public ContactKoshiro Nishimoto

Saitama Medical University International Medical Center UroOncology

k.nishimoto@keio.jp+81-42-984-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026